Global News

BTC Network rebrands, acquires Novex Clinical Research

Tuesday, August 2, 2016

BTC Network, a fully integrated network of clinical research sites in the U.S., has strengthened its site operations with the recent acquisition of Novex Clinical Research, a multi-specialty research practice in New Bedford, Massachusetts. As a result of the deal, Novex Clinical Research will be the first clinical research site to be owned and operated under the BTC Network umbrella. It will strengthen BTC Network’s expertise and commitment to therapeutic areas such as psychiatry, neurology, pain, and internal medicine.

[Read More]

Takeda refocuses R&D, concentrating in Japan and the U.S.

Monday, August 1, 2016

Takeda Pharmaceutical plans to accelerate the R&D organization transformation by refocusing on three key therapeutic areas—Oncology, Gastroenterology (GI) and Central Nervous System (CNS), plus Vaccines, and concentrating R&D activities in Japan and the U.S. This transformation is critical to provide the company with the necessary organizational and financial flexibility to drive innovation, enhance partnerships, and improve R&D productivity for long-term, sustainable growth. Takeda will optimize its R&D sites globally.

[Read More]

BioAdvance commits $2.9M to 15 life sciences companies

Monday, August 1, 2016

BioAdvance announced that during the past 12 months it added nine new companies and technologies to its portfolio and made follow-on investments in six of its existing companies. Overall, these investments represent a $2.9 million commitment to the success and growth of life science companies and to this region.

[Read More]